Browsing: Ultracentral

HILUS was a trial of SBRT for ultracentral NSCLC that had an unacceptably high rate of grade 5 adverse events…

SUNSET was a phase 1 study that evaluated 60 Gy in 8 fractions for ultracentral lung tumors. It included 30…

Ultracentral lung SBRT deserves caution in the up-front setting, so how safe is it in the reirradiation setting? In this…

Top Line: Is 60 Gy in 8 fractions a safe option for patients with central NSCLC?The Study: EORTC 22113-08113 (LungTech)…

Top Line: Can SBRT be used to treat mediastinal nodes?The Study: As much as we fret over using SBRT for…

Standard SBRT for ultra-central lung tumors has been associated with an increased risk of severe toxicity particularly from the central…